- By David Marks, Medical Director of IMPACT. Stem cell transplants give a second chance of life to 4,400[i] people a year in the UK, but sadly, fewer than half of…
- A healthy gut We have known for a long time that our digestive system is home to billions of tiny microbes that help us digest our food properly. We are even encouraged to look…
- Graft vs Host Disease (GvHD) is a common complication for many patients during their recovery after a stem cell transplant. It’s caused by small differences between the new…
- Jonathan in the Patient Services team discusses recent research into the use of cell therapies to treat Graft versus Host Disease (GvHD), which is a common side effect of stem…
- Daniel Gibson, Head of Innovation and Commercialisation talks about the advancements in cellular therapy research, and how we are overcoming critical issues in the supply of…
- Jonathan in our patient services team discusses emerging treatments for cancer, using cell therapy and new ‘super cells’. When developing a new cancer treatment, one of the…
- New findings from Patient/Donor project New findings from Anthony Nolan’s flagship Patient/Donor project have shown that sometimes a perfect match isn’t always…
- After the news that the Scottish Medicine Consortium has recommended letermovir (Prevymis) for routine use on the NHS in Scotland, Bradley from our Policy and Public Affairs team…
- Daniel Gibson, Anthony Nolan’s Assistant Director of the Cell and Gene Therapy Service, talks about the enormous potential of cord blood as a starting material in research to…
- Daniel Gibson, Anthony Nolan’s Assistant Director of the Cell and Gene Therapy Service, talks about the importance of where starting materials come from and how the Anthony…
This page has been auto translated by Google Translate. Confirm any health information with your own medical team before acting upon it. All printed materials and PDFs are available in English only.